<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药云端工作室 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-19T20:46:51+08:00</updated>
  <subtitle>医药行业领先的智库，连接政策与市场的桥梁</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>江苏药品集采结果出炉，最高降幅93%！</title>
    <updated>2021-01-19T19:12:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/ycy7zVYP0tP_FxT42DlaFA</id>
    <link href="https://mp.weixin.qq.com/s/ycy7zVYP0tP_FxT42DlaFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一万年太久，做好产品只争朝夕！</title>
    <updated>2021-01-19T19:12:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/W1VNl3EcVaUo6cOFJ9u3VA</id>
    <link href="https://mp.weixin.qq.com/s/W1VNl3EcVaUo6cOFJ9u3VA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>又有4款药品修订说明书，涉超10亿独家大品种</title>
    <updated>2021-01-19T19:12:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/7SvOzMOpUlGTXJdrimeNcQ</id>
    <link href="https://mp.weixin.qq.com/s/7SvOzMOpUlGTXJdrimeNcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>进军东南亚市场，信达生物授予Etana“贝伐珠单抗”独家许可</title>
    <updated>2021-01-19T19:12:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/d_2cuukiSWJa8uQzcNCWIA</id>
    <link href="https://mp.weixin.qq.com/s/d_2cuukiSWJa8uQzcNCWIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采：总采购规模及“缩水”程度分析</title>
    <updated>2021-01-18T20:28:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/_rkO9h-dTuE1uZjdIMFdoQ</id>
    <link href="https://mp.weixin.qq.com/s/_rkO9h-dTuE1uZjdIMFdoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>耗材第二批国采将于近期开展，或涉6大类</title>
    <updated>2021-01-18T20:28:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/irR_9v-CbIyOegw1X3OtHg</id>
    <link href="https://mp.weixin.qq.com/s/irR_9v-CbIyOegw1X3OtHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专家解读：国产新冠疫苗上市审批流程是什么？</title>
    <updated>2021-01-18T20:28:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/6rKtJ3sLgpP6kzPMIqsgkA</id>
    <link href="https://mp.weixin.qq.com/s/6rKtJ3sLgpP6kzPMIqsgkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020全年800多个医药政策！重点政策105项，影响所有医药人</title>
    <updated>2021-01-18T20:28:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/xvLTQzaLFgN3dTEJLT_oag</id>
    <link href="https://mp.weixin.qq.com/s/xvLTQzaLFgN3dTEJLT_oag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【持续跟踪99周】本周新增9品种过评，酮咯酸氨丁三醇片、乳酸环丙沙星氯化钠注射液迎首家</title>
    <updated>2021-01-17T18:19:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/V-Th6tkQCAr_8WbzVcH95A</id>
    <link href="https://mp.weixin.qq.com/s/V-Th6tkQCAr_8WbzVcH95A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年，299位药企高管离职（附名单）</title>
    <updated>2021-01-17T18:19:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/4abC2WOGX-ZHH5NFA8fFAQ</id>
    <link href="https://mp.weixin.qq.com/s/4abC2WOGX-ZHH5NFA8fFAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采将于2月3日开标；2021年销量前500个品种是集采重点；多省要求企业“自首”失信行为｜云端周报</title>
    <updated>2021-01-17T18:19:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/KfrwHKNdRyjoFDRAH9c24Q</id>
    <link href="https://mp.weixin.qq.com/s/KfrwHKNdRyjoFDRAH9c24Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021：集采及医保目录准入，重新定义医药行业发展</title>
    <updated>2021-01-16T17:47:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/tM8nzNx5PbLp0AHYReY8hg</id>
    <link href="https://mp.weixin.qq.com/s/tM8nzNx5PbLp0AHYReY8hg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>6726个品种被取消采购！</title>
    <updated>2021-01-16T17:47:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/XO7RqFVliwCLMJGRJQsEtg</id>
    <link href="https://mp.weixin.qq.com/s/XO7RqFVliwCLMJGRJQsEtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采正式开启！45个品种纳入，2月3日开标</title>
    <updated>2021-01-15T18:03:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/2WWnPdPHE8cN1ysboa8jvg</id>
    <link href="https://mp.weixin.qq.com/s/2WWnPdPHE8cN1ysboa8jvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注意！涉严重不良反应，2款药品被召回，注销药品注册批件！</title>
    <updated>2021-01-15T18:03:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/TRSULL4f4vV9-oIYIsBBNA</id>
    <link href="https://mp.weixin.qq.com/s/TRSULL4f4vV9-oIYIsBBNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集采结果出炉：安徽60品种中选，省际联盟2品种议价入围</title>
    <updated>2021-01-15T18:03:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/HW4IBRTPPyAPWfqx35DmOA</id>
    <link href="https://mp.weixin.qq.com/s/HW4IBRTPPyAPWfqx35DmOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保基金专项治理启动，5类问题需注意</title>
    <updated>2021-01-15T18:03:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/4tdq8vCv2ueQLBlbwG7qpg</id>
    <link href="https://mp.weixin.qq.com/s/4tdq8vCv2ueQLBlbwG7qpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判品种大幅降价挂网，礼来、豪森打响第一炮！</title>
    <updated>2021-01-14T17:43:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/shojO-WggiWXWU_ae_WDUA</id>
    <link href="https://mp.weixin.qq.com/s/shojO-WggiWXWU_ae_WDUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品价格管理办法或将出台</title>
    <updated>2021-01-14T17:43:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/nPHm3EKcX5I6kNDvmt1zWA</id>
    <link href="https://mp.weixin.qq.com/s/nPHm3EKcX5I6kNDvmt1zWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新一轮拟优先审评审批名单出炉，恒瑞、思路迪/康宁杰瑞、苏庇医药等在列！</title>
    <updated>2021-01-14T17:43:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/7tQlEVHZ-IwHx8J6t9VGDQ</id>
    <link href="https://mp.weixin.qq.com/s/7tQlEVHZ-IwHx8J6t9VGDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>